IL-17 plays a central role in autoimmune disease.American food and drug administration (FDA)approved monoclonal antibodies against IL-17and its receptors, indicating the importance ofsuppression of this gene and its receptors ADstreatments (22). This evidence concerns the gene IL17A and autoimmune disease.